Cannabis and Driving Impairment Laws
How different jurisdictions handle stoned driving, why THC blood limits are scientifically messy, and what the evidence actually shows.
Driving while impaired by cannabis is genuinely dangerous and illegal everywhere. But the legal frameworks used to enforce that — especially per se THC blood limits — have a real scientific problem: THC can linger in blood for days or weeks in frequent users who are no longer impaired. That means a sober regular consumer can fail a per se test. Laws are a patchwork, change frequently, and police testing methods are inconsistent. Don't drive high. Also, know your local rules before you carry product in a vehicle.
Not legal advice
This article is informational only and is not legal advice. Cannabis driving laws vary by country, state, province, and even municipality, and they change often. Penalties can include license suspension, heavy fines, criminal records, and jail. If you are facing a charge or need to know the law where you live, consult a licensed attorney in your jurisdiction. Information here was last verified in January 2025 and may be out of date by the time you read it.
The core rule everywhere: don't drive impaired
Every jurisdiction that has legalized or decriminalized cannabis still prohibits driving while impaired by it. This is true in all US legal states, all Canadian provinces, Germany, the Netherlands, Thailand, Uruguay, and so on. The disagreement is not about whether stoned driving is illegal — it's about how to prove impairment.
Meta-analyses find that acute cannabis intoxication roughly doubles crash risk, which is meaningful but substantially lower than alcohol at common impairing levels Strong evidence [1][2]. Combining cannabis with alcohol is worse than either alone Strong evidence [2].
Two legal frameworks: impairment-based vs. per se
Jurisdictions generally use one of two approaches, sometimes both:
1. Impairment-based (effect-based) laws. The prosecution must show the driver was actually impaired — through driving behavior, field sobriety tests, and often a Drug Recognition Expert (DRE) evaluation. Canada uses this alongside per se limits; many US states rely on it when blood THC is below the per se threshold [3].
2. Per se laws. A blood (or sometimes oral fluid) THC concentration at or above a fixed number is itself the offense, regardless of observed impairment. Examples: Washington, Montana, and Ohio use 5 ng/mL of Δ9-THC in whole blood; Nevada uses 2 ng/mL; Pennsylvania uses 1 ng/mL; the UK uses 2 µg/L; Germany raised its limit to 3.5 ng/mL in August 2024 after legalization [4][5][6].
3. Zero-tolerance laws. Any detectable THC — or in some places, any detectable inactive metabolite like THC-COOH — is an offense. Arizona, Georgia, Illinois (historically, for metabolites), Indiana, and several others have used this approach; so do Japan, South Korea, and the UAE. Illinois moved away from metabolite-based zero tolerance for medical patients in 2016 [3].
Why per se THC limits are scientifically contested
Blood THC does not track impairment the way blood alcohol does. Key issues:
- THC redistributes quickly out of blood into fat. Peak blood THC after smoking often occurs before peak impairment, and falls rapidly even while the user is still high Strong evidence [7].
- Frequent users carry residual THC. Daily cannabis users have measurable blood THC for days or weeks of abstinence, sometimes above 5 ng/mL, with no acute impairment Strong evidence [7][8].
- Edibles produce different blood curves. Oral THC produces lower peak blood concentrations than smoking despite strong impairment Strong evidence [7].
- NHTSA itself has stated that a specific blood THC threshold cannot reliably predict impairment [8].
The practical consequence: a sober regular consumer can fail a 5 ng/mL test, while an occasional user who is genuinely impaired can pass it an hour or two after smoking. Some researchers and advocacy groups (including AAA Foundation for Traffic Safety) have argued per se THC limits should be abandoned in favor of impairment-based enforcement [8]. Courts in some jurisdictions have pushed back on rigid numerical standards for the same reason.
How testing actually works
Roadside testing in cannabis cases typically follows a chain:
- Behavioral observation and Standardized Field Sobriety Tests (SFSTs). Originally validated for alcohol; their sensitivity to cannabis impairment is modest Weak / limited [9].
- Oral fluid (saliva) screening. Devices like Dräger DrugTest 5000 and SoToxa detect recent THC use, generally within a few hours. Used roadside in the UK, Australia, Canada, and parts of the US. Sensitivity and specificity vary significantly between devices Weak / limited [10].
- Drug Recognition Expert (DRE) evaluation. A trained officer performs a 12-step protocol. Court acceptance varies; defense challenges to DRE testimony are common.
- Blood draw. The evidentiary test in most per se jurisdictions. Usually requires a warrant in the US after Missouri v. McNeely (2013) and Mitchell v. Wisconsin (2019), unless the driver consents or an exception applies.
Urine tests detect THC-COOH, an inactive metabolite, for days to weeks. They cannot establish impairment and are generally not used as the primary evidence for DUI, though they are standard in US Department of Transportation safety-sensitive employment testing [11].
Selected jurisdictions at a glance
Last verified January 2025. Confirm locally before relying on any of this.
- Canada: Two-tier per se under the Criminal Code — 2 to <5 ng/mL THC is a summary offense; ≥5 ng/mL, or ≥2.5 ng/mL combined with ≥50 mg/100 mL alcohol, is a more serious hybrid offense. Impairment-based charges also available [5].
- United States (federal): No per se THC limit. Commercial drivers under DOT rules face zero tolerance via urine testing.
- Colorado: 5 ng/mL blood THC creates a permissible inference of impairment, not automatic guilt — unusual among per se states [3].
- Washington, Montana, Ohio, Illinois (recreational drivers): 5 ng/mL per se.
- Nevada: 2 ng/mL blood THC per se.
- Pennsylvania: 1 ng/mL — among the strictest in the US.
- United Kingdom: 2 µg/L blood THC under the Road Traffic Act 1988 as amended in 2015 [4].
- Germany: 3.5 ng/mL blood serum THC as of August 2024, replacing the prior 1.0 ng/mL analytical threshold [6].
- Australia: Zero tolerance for presence of THC in most states, enforced via roadside oral fluid testing.
- Japan, South Korea, UAE, Singapore: Cannabis itself is heavily criminalized; any detected use, driving or not, can carry severe penalties.
Practical takeaways
- Don't drive impaired. The crash-risk evidence is real, and the legal consequences are serious even in legal states.
- Wait time after smoking is uncertain, but acute impairment from inhaled THC generally lasts 3–4 hours, sometimes longer for higher doses or less experienced users Strong evidence [7]. Edibles can impair for 6–8 hours or more.
- If you are a daily consumer, understand that you may carry blood THC above per se limits for days while sober. This is a real legal exposure that current law has not solved.
- Transporting legal cannabis in a vehicle is regulated separately (sealed container, trunk, etc.) and varies by state — check local rules.
- If stopped, you have the same rights as in any traffic stop. Specifics on consent to testing vary; implied consent laws often apply to chemical tests, with license suspension for refusal.
Sources
- Peer-reviewed Rogeberg, O., & Elvik, R. (2016). The effects of cannabis intoxication on motor vehicle collision revisited and revised. Addiction, 111(8), 1348–1359.
- Peer-reviewed Asbridge, M., Hayden, J. A., & Cartwright, J. L. (2012). Acute cannabis consumption and motor vehicle collision risk: systematic review of observational studies and meta-analysis. BMJ, 344, e536.
- Government National Conference of State Legislatures (NCSL). Cannabis Impaired Driving (state-by-state summary). Updated periodically. ↗
- Government UK Government. Drug driving (drink and drug driving law) — Section 5A Road Traffic Act 1988. ↗
- Government Government of Canada. Criminal Code provisions on drug-impaired driving (s. 253, s. 320.14) and Blood Drug Concentration Regulations (SOR/2018-148). ↗
- Reported Deutsche Welle / Reuters coverage of Germany's August 2024 introduction of a 3.5 ng/mL THC blood serum limit for drivers following partial cannabis legalization. ↗
- Peer-reviewed Huestis, M. A. (2007). Human cannabinoid pharmacokinetics. Chemistry & Biodiversity, 4(8), 1770–1804.
- Government Compton, R. (2017). Marijuana-Impaired Driving: A Report to Congress. National Highway Traffic Safety Administration (NHTSA), DOT HS 812 440. ↗
- Peer-reviewed Papafotiou, K., Carter, J. D., & Stough, C. (2005). The relationship between performance on the standardised field sobriety tests, driving performance and the level of Δ9-tetrahydrocannabinol (THC) in blood. Forensic Science International, 155(2–3), 172–178.
- Peer-reviewed Logan, B., et al. (2018). An Evaluation of Data from Drivers Arrested for Driving Under the Influence in Relation to Per Se Limits for Cannabis. AAA Foundation for Traffic Safety. ↗
- Government US Department of Transportation. 49 CFR Part 40 — Procedures for Transportation Workplace Drug and Alcohol Testing Programs. ↗
How this page was made
Generation history
Drafting assistance and fact-check automation are used, with a human operator spot-checking on a weekly basis. See how articles are made.